GARD®potency.

Skin sensitizing potency sub-categorization according to GHS/CLP

Allergic contact dermatitis is the most prevalent form of immunotoxic adverse effects induced by chemicals in consumer products and everyday surroundings. The symptomatic rash is caused by an immune response towards foreign substances in direct contact with the skin.

GARDpotency is an add-on to GARDskin, able to subcategorize sensitizers according to CLP/GHS classifications, by monitoring the expression of ~50 complementary genomic biomarkers.

The new guidelines for REACH registrations of chemicals include CLP categorization of skin sensitizers as Cat 1A for strong sensitizers, Cat 1B for moderate sensitizers and No Cat for non-sensitizers. This is the specific end-point of GARDpotency.

More information

Find out more about the GARD tests in our product sheets or let our specialists explain the technology more thoroughly to you.

DOWNLOAD PRODUCT FACTS

51 genes

Complements to GARDskin for potency classification.

  • Develop safer products, comply with regulatory information requirements, and enable product hazard labeling according to GHS/CLP
  • Genomic readout of 51 genes relevant to skin sensitization.
  • State-of-the-art machine learning to compare patterns of gene expressions.
  • 82% accuracy for hazard assessment and GHS/ CLP potency sub-categorization reported in an OECD validation study.
  • Turnaround time: 4-6 weeks.
  • Sample requirements: 0.5 g (solids) or 1 ml (liquids).

Suitable for

  • Industrial chemicals
  • Chemicals in consumer products
  • Screening of pharmaceutical candidates

Subscribe


Prenumerera